Yahoo
NasdaqGM - Delayed Quote USD

Cronos Group Inc. (CRON)

3.2600 0.0000 (0.00%)
At close: September 4 at 4:00:01 PM EDT
3.2589 -0.0011 (-0.03%)
After hours: September 4 at 7:43:01 PM EDT
Trade CRON on Coinbase
Chart Range Bar
Loading chart for CRON
  • Previous Close 3.2600
  • Open 3.2300
  • Bid 2.4000 x 100
  • Ask 3.2400 x 100
  • Day's Range 3.2150 - 3.2700
  • 52 Week Range 2.2800 - 3.6080
  • Volume 493,585
  • Avg. Volume 1,183,687
  • Market Cap (intraday) 1.201B
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) 17.16
  • EPS (TTM) 0.1900
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.54

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

thecronosgroup.com

610

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CRON
24.43%
S&P/TSX Composite index (^GSPTSE)
14.58%

1-Year Return

CRON
30.40%
S&P/TSX Composite index (^GSPTSE)
26.28%

3-Year Return

CRON
65.48%
S&P/TSX Composite index (^GSPTSE)
77.72%

5-Year Return

CRON
49.85%
S&P/TSX Composite index (^GSPTSE)
75.37%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 53.01M
Earnings 32.09M
Profit Margin 60.53%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
10M
20M
30M
40M
50M
0.0%
20.0%
40.0%
60.0%

Analyst Insights

View More

Analyst Price Targets

2.54 Low
2.54 Average
3.2600 Current
2.54

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/15/2024
Analyst CIBC
Rating Action Maintains
Rating Outperformer
Price Action Raises
Price Target 3 -> 3.5

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    39.08%

  • Return on Assets (ttm)

    -0.10%

  • Return on Equity (ttm)

    7.05%

  • Revenue (ttm)

    179.09M

  • Net Income Avi to Common (ttm)

    69.98M

  • Diluted EPS (ttm)

    0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    797.02M

  • Total Debt/Equity (mrq)

    0.12%

  • Levered Free Cash Flow (ttm)

    6.11M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: